ASTERIX: Low Dose ASA and Nexium

Sponsor
AstraZeneca (Industry)
Overall Status
Completed
CT.gov ID
NCT00251966
Collaborator
(none)
960
93
16
10.3
0.6

Study Details

Study Description

Brief Summary

The purpose of the study is to evaluate the effect of esomeprazole 20 mg od versus placebo for the prevention of gastric and/or duodenal ulcers in patients taking low-dose ASA.

Condition or Disease Intervention/Treatment Phase
Phase 3

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Prevention
Official Title:
A Randomized Double-Blind Placebo-Controlled Study to Assess the Prevention of Low-Dose Acetylsalicylic Acid (ASA) Associated Gastroduodenal Lesions and Upper Gastrointestinal Symptoms in Patients Taking Esomeprazole 20 mg Once Daily for 26 Weeks.
Study Start Date :
May 1, 2004
Actual Study Completion Date :
Sep 1, 2005

Outcome Measures

Primary Outcome Measures

  1. The primary variable is presence of gastric and/or duodenal ulcers at endoscopy over a 26-week period in patients taking low-dose ASA. []

Secondary Outcome Measures

  1. LA classification for the oesophagus at endoscopy. Upper GI symptoms assessed by the investigator at each study visit. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • A clinical diagnosis of a condition (cardiovascular and/or cerebrovascular protection or other reasons) that requires daily intake of low-dose ASA, 75-325 mg, and is expected to continue for the duration of the study (daily is defined as at least 5 days per week).

  • Age >= 60 years.

  • No gastric and/or duodenal ulcer at the baseline endoscopy.

    1. pylori negative by serology test at screening.
Exclusion Criteria:
  • Upper GI symptoms

  • Erosive oesophagitis

  • Malignancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Research Site Bondi Junction New South Wales Australia
2 Research Site Bracken Ridge Queensland Australia
3 Research Site Carina Heights Queensland Australia
4 Research Site Adelaide South Australia Australia
5 Research Site Ashford South Australia Australia
6 Research Site Wayville South Australia Australia
7 Research Site Woodville South Australia Australia
8 Research Site Ballarat Victoria Australia
9 Research Site Malvern Victoria Australia
10 Research Site Burgas Bulgaria
11 Research Site Pleven Bulgaria
12 Research Site Russe Bulgaria
13 Research Site Sofia Bulgaria
14 Research Site Varna Bulgaria
15 Research Site Edmonton Alberta Canada
16 Research Site Winnipeg Manitoba Canada
17 Research Site Bay Roberts Newfoundland and Labrador Canada
18 Research Site Carbonear Newfoundland and Labrador Canada
19 Research Site St. John's Newfoundland and Labrador Canada
20 Research Site Halifax Nova Scotia Canada
21 Research Site Hamilton Ontario Canada
22 Research Site London Ontario Canada
23 Research Site North York Ontario Canada
24 Research Site Oakville Ontario Canada
25 Research Site Sudbury Ontario Canada
26 Research Site Thornhill Ontario Canada
27 Research Site Toronto Ontario Canada
28 Research Site Parkdale Prince Edward Island Canada
29 Research Site Courcelette Quebec Canada
30 Research Site Quebec Canada
31 Research Site Stuttgart Baden-Württemberg Germany
32 Research Site München Bayern Germany
33 Research Site Cottbus Brandenburg Germany
34 Research Site Frankfurt Hessen Germany
35 Research Site Rostock Mecklenburg-Vorpommern Germany
36 Research Site Hannover Niedersachsen Germany
37 Research Site Düsseldorf Nordrhein-Westfalen Germany
38 Research Site Münster Nordrhein-Westfalen Germany
39 Research Site Mainz Rheinland-Pfalz Germany
40 Research Site Halle Sachsen-Anhalt Germany
41 Research Site Hamburg Germany
42 Research Site Herne Germany
43 Research Site Köln Germany
44 Research Site Künzing Germany
45 Research Site Lienen Germany
46 Research Site Ludwigshafen Germany
47 Research Site Lüdenscheid Germany
48 Research Site Münster Germany
49 Research Site Oelde Germany
50 Research Site Paderborn Germany
51 Research Site Potsdam Germany
52 Research Site Ribnitz-Damgarten Germany
53 Research Site Rostock Germany
54 Research Site Siegen Germany
55 Research Site Wangen Germany
56 Research Site Wiesbaden Germany
57 Research Site Wolfenbüttel Germany
58 Research Site Wolmirstedt Germany
59 Research Site Zeven Germany
60 Research Site Athens Greece
61 Research Site Ioannina Greece
62 Research Site Piraeus Greece
63 Research Site Thessaloniki Greece
64 Research Site Hong Kong Hong Kong
65 Research Site Budapest Hungary
66 Research Site Debrecen Hungary
67 Research Site Eger Hungary
68 Research Site Gyula Hungary
69 Research Site Gy¿r Hungary
70 Research Site Kecskemét Hungary
71 Research Site Miskolc Hungary
72 Research Site Vác Hungary
73 Research Site Bologna BO Italy
74 Research Site Genova GE Italy
75 Research Site Parma PR Italy
76 Research Site Napoli Italy
77 Research Site Roma Italy
78 Research Site Cape Town South Africa
79 Research Site Johannesurg South Africa
80 Research Site Lyttelton Manor South Africa
81 Research Site Parktown South Africa
82 Research Site Tygerberg South Africa
83 Research Site Santiago de Compostela A Coruña Spain
84 Research Site Santiago A Coruña Spain
85 Research Site San Sebastián Guipuzcoa Spain
86 Research Site Granada Spain
87 Research Site Madrid Spain
88 Research Site Murcia Spain
89 Research Site Sevilla Spain
90 Research Site Irvine Ayrshire United Kingdom
91 Research Site Glasgow Scotland United Kingdom
92 Research Site Cardiff South Wales United Kingdom
93 Research Site Edinburgh United Kingdom

Sponsors and Collaborators

  • AstraZeneca

Investigators

  • Study Director: AstraZeneca Nexium Medical Science Director, MD, AstraZeneca
  • Principal Investigator: Neville Yeomans, MD, Perth Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00251966
Other Study ID Numbers:
  • D9617C00011
First Posted:
Nov 11, 2005
Last Update Posted:
Mar 12, 2009
Last Verified:
Mar 1, 2009

Study Results

No Results Posted as of Mar 12, 2009